Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.

Hussein J, Zewdie M, Yamuah L, Bedru A, Abebe M, Dagnew AF, Chanyalew M, Yohannes AG, Ahmed J, Engers H, Doherty TM, Bang P, Kromann I, Hoff ST, Aseffa A.

Trials. 2018 Jan 10;19(1):24. doi: 10.1186/s13063-017-2354-0.

2.

A pilot study on detection and genotyping of humanpapilloma virus isolated from clinically diagnosed Ethiopian women having cervical intraepithelial neoplasia.

Mihret W, Yusuf L, Abebe M, Yamuah LK, Bekele L, Abate E, Wassie L, Engers H, Aseffa A.

Ethiop Med J. 2014 Jan;Suppl 1:49-52.

PMID:
24696989
3.

Chronic meningitis in immunocompromised adult Ethiopians visiting Tikur Anbessa Teaching Hospital and Ye'huleshet Clinic from 2003-2004.

Mihret W, Zenebe G, Bekele A, Abebe M, Wassie L, Yamuah LK, Woldemeskel D, Kassahun Y, Medhin G, Engers H, Aseffa A.

Ethiop Med J. 2014 Jan;Suppl 1:43-8.

PMID:
24696988
4.

Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan.

Abate E, Aseffa A, El-Tayeb M, El-Hassan I, Yamuah L, Mihret W, Bekele L, Ashenafi S, El-Dawi N, Belayneh M, El-Hassan A, Engers H.

J Med Virol. 2013 Feb;85(2):282-7. doi: 10.1002/jmv.23437. Epub 2012 Nov 14.

PMID:
23160919
5.

TB case detection: can we remain passive while the process is active?

Abebe M, Doherty M, Wassie L, Demissie A, Mihret A, Engers H, Aseffa A.

Pan Afr Med J. 2012;11:50. Epub 2012 Mar 19.

6.

Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Gadisa E, Custodio E, Cañavate C, Sordo L, Abebe Z, Nieto J, Chicharro C, Aseffa A, Yamuah L, Engers H, Moreno J, Cruz I.

Am J Trop Med Hyg. 2012 May;86(5):792-8. doi: 10.4269/ajtmh.2012.11-0196.

7.

Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia.

Negera E, Gadisa E, Hussein J, Engers H, Kuru T, Gedamu L, Aseffa A.

Trans R Soc Trop Med Hyg. 2012 Aug;106(8):496-503. doi: 10.1016/j.trstmh.2012.02.006. Epub 2012 Apr 12.

PMID:
22503475
8.

Multidrug resistant Salmonella Concord is a major cause of salmonellosis in children in Ethiopia.

Beyene G, Nair S, Asrat D, Mengistu Y, Engers H, Wain J.

J Infect Dev Ctries. 2011 Feb 1;5(1):23-33.

9.

Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.

Abebe M, Kim L, Rook G, Aseffa A, Wassie L, Zewdie M, Zumla A, Engers H, Andersen P, Doherty TM.

Clin Dev Immunol. 2011;2011:678570. doi: 10.1155/2011/678570. Epub 2011 Jan 4.

10.

Leishmania donovani complex (Kinetoplastida, Trypanosomatidae): comparison of deoxyribonucleic acid based techniques for typing of isolates from Ethiopia.

Gadisa E, Kuru T, Genet A, Engers H, Aseffa A, Gedamu L.

Exp Parasitol. 2010 Oct;126(2):203-8. doi: 10.1016/j.exppara.2010.04.026. Epub 2010 Jun 11.

PMID:
20438727
11.

Insecticide resistance in Anopheles arabiensis (Diptera: Culicidae) from villages in central, northern and south west Ethiopia and detection of kdr mutation.

Balkew M, Ibrahim M, Koekemoer LL, Brooke BD, Engers H, Aseffa A, Gebre-Michael T, Elhassen I.

Parasit Vectors. 2010 Apr 25;3(1):40. doi: 10.1186/1756-3305-3-40.

12.

Serodiagnosis of tuberculous lymphadenitis using a combination of antigens.

Beyene D, Lumc Franken K, Yamuah L, Aseffa A, Wiker HG, Kolk A, Engers H, Klatser P, Sviland L.

J Infect Dev Ctries. 2010 Mar 8;4(2):96-102.

13.

Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status.

Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, Demissie A, Zewdie M, Engers H, Andersen P, Kim L, Huggett J, Rook G, Yamuah LK, Zumla A; VACSEL study group.

Eur J Immunol. 2010 Jan;40(1):291-301. doi: 10.1002/eji.200939856.

14.

Identification and genotyping of the etiological agent of tuberculous lymphadenitis in Ethiopia.

Beyene D, Bergval I, Hailu E, Ashenafi S, Yamuah L, Aseffa A, Wiker HG, Engers H, Klatser P, Sviland L.

J Infect Dev Ctries. 2009 Jul 1;3(6):412-9.

15.

The burden of mycobacterial disease in ethiopian cattle: implications for public health.

Berg S, Firdessa R, Habtamu M, Gadisa E, Mengistu A, Yamuah L, Ameni G, Vordermeier M, Robertson BD, Smith NH, Engers H, Young D, Hewinson RG, Aseffa A, Gordon SV.

PLoS One. 2009;4(4):e5068. doi: 10.1371/journal.pone.0005068. Epub 2009 Apr 7. Erratum in: PLoS One. 2009;4(4). doi: 10.1371/annotation/f7240b30-f202-45c5-aacb-4fda2efb8b3d.

16.

Validation of bleach-treated smears for the diagnosis of pulmonary tuberculosis.

Merid Y, Yassin MA, Yamuah L, Kumar R, Engers H, Aseffa A.

Int J Tuberc Lung Dis. 2009 Jan;13(1):136-41.

PMID:
19105892
17.

Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits.

Reed ZH, Kieny MP, Engers H, Friede M, Chang S, Longacre S, Malhotra P, Pan W, Long C.

Vaccine. 2009 Mar 4;27(10):1651-60. doi: 10.1016/j.vaccine.2008.10.093. Epub 2008 Nov 25.

PMID:
19038302
18.

Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.

Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H.

Malar J. 2008 Oct 29;7:220. doi: 10.1186/1475-2875-7-220.

19.

Diagnosis of tuberculous lymphadenitis in Ethiopia: correlation with culture, histology and HIV status.

Beyene D, Ashenafi S, Yamuah L, Aseffa A, Wiker H, Engers H, Klatser P, Sviland L.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1030-6.

PMID:
18713500
20.

Editorial: leprosy research and current priorities in Ethiopia.

Aseffa A, Engers H, Leekassa R.

Ethiop Med J. 2007 Oct;45 Suppl 1:2p preceding 1. No abstract available.

PMID:
18710068
21.

Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.

Boraschi D, Abebe Alemayehu M, Aseffa A, Chiodi F, Chisi J, Del Prete G, Doherty TM, Elhassan I, Engers H, Gyan B, Harandi AM, Kariuki T, Kironde F, Kouriba B, Langhorne J, Laskay T, Medaglini D, Olesen O, Onyebujoh P, Palma C, Sauerwein R, Sibanda E, Steinhoff U, Tagliabue A, Thiel A, Vahedi M, Troye-Blomberg M.

PLoS Negl Trop Dis. 2008 Jun 25;2(6):e255. doi: 10.1371/journal.pntd.0000255.

22.

Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Elias D, Britton S, Aseffa A, Engers H, Akuffo H.

Vaccine. 2008 Jul 23;26(31):3897-902. doi: 10.1016/j.vaccine.2008.04.083. Epub 2008 May 21.

PMID:
18554755
23.

Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification.

Negera E, Gadisa E, Yamuah L, Engers H, Hussein J, Kuru T, Hailu A, Gedamu L, Aseffa A.

Trans R Soc Trop Med Hyg. 2008 Sep;102(9):883-90. doi: 10.1016/j.trstmh.2008.03.021. Epub 2008 May 13.

PMID:
18479722
24.

Effect of skin testing and segregation on the prevalence of bovine tuberculosis, and molecular typing of Mycobacterium bovis, in Ethiopia.

Ameni G, Aseffa A, Sirak A, Engers H, Young DB, Hewinson RG, Vordermeier MH, Gordon SV.

Vet Rec. 2007 Dec 8;161(23):782-6.

25.

High prevalence and increased severity of pathology of bovine tuberculosis in Holsteins compared to zebu breeds under field cattle husbandry in central Ethiopia.

Ameni G, Aseffa A, Engers H, Young D, Gordon S, Hewinson G, Vordermeier M.

Clin Vaccine Immunol. 2007 Oct;14(10):1356-61. Epub 2007 Aug 29.

26.

Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia.

Diro E, Techane Y, Tefera T, Assefa Y, Kebede T, Genetu A, Kebede Y, Tesfaye A, Ergicho B, Gebre-Yohannes A, Mengistu G, Engers H, Aseffa A, Desjeux P, Boelaert M, Hailu A.

Trans R Soc Trop Med Hyg. 2007 Sep;101(9):908-14. Epub 2007 Jul 10.

PMID:
17624385
27.

Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia.

Aseffa A, Bedru A, Yamuah L, Arga D, Worku A, Chandramohan D, Nelson CB, Engers HD.

Vaccine. 2007 Sep 3;25 Suppl 1:A79-82. Epub 2007 May 4.

PMID:
17548138
28.

Very high DDT-resistant population of Anopheles pharoensis Theobald (Diptera: Culicidae) from Gorgora, northern Ethiopia.

Balkew M, Elhassen I, Ibrahim M, Gebre-Michael T, Engers H.

Parasite. 2006 Dec;13(4):327-9.

29.

Knowledge and practice of private practitioners in TB control in Addis Ababa.

Shimeles E, Aseffa A, Yamuah L, Tilahun H, Engers H.

Int J Tuberc Lung Dis. 2006 Oct;10(10):1172-7.

PMID:
17044213
30.
31.

Malaria vaccine development: current status.

Engers HD, Godal T.

Parasitol Today. 1998 Feb;14(2):56-64.

PMID:
17040699
32.
33.

Recent contributions to mycobactrial research and capacity building in Ethiopia.

Aseffa A, Engers H.

Ethiop Med J. 2004 Apr;42 Suppl 1:1 p following table of contents. No abstract available.

PMID:
16895013
34.

[Anti-malarial vaccination today].

Engers HD.

Bull Soc Pathol Exot. 2001 Jul;94(2 Pt 2):147-8. French. No abstract available.

PMID:
16579067
35.

Leprosy.

Engers H, Morel CM.

Nat Rev Microbiol. 2003 Nov;1(2):94-5. doi: 10.1038/nrmicro764. No abstract available.

PMID:
15035038
36.
37.

Strategic emphases for tropical diseases research: a TDR perspective.

Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM.

Trends Parasitol. 2002 Oct;18(10):421-6. Review.

PMID:
12377584
38.

Strategic emphases for tropical diseases research: a TDR perspective.

Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM.

Trends Microbiol. 2002 Oct;10(10):435-40.

PMID:
12377547
39.

Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December 2001, Ho Chi Minh City, VietNam.

Almond J, Clemens J, Engers H, Halstead S, Khiem HB, Pablos-Mendez A, Pervikov Y, Tram TT.

Vaccine. 2002 Aug 19;20(25-26):3043-6. No abstract available.

PMID:
12163253
40.

2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5-7 June 2000.

Kenney RT, Regina Rabinovich N, Pichyangkul S, Price VL, Engers HD.

Vaccine. 2002 May 22;20(17-18):2155-63. No abstract available.

PMID:
12009267
41.
42.

Progress on vaccines against parasites.

Engers HD, Bergquist R, Modabber F.

Dev Biol Stand. 1996;87:73-84. Review.

PMID:
8854004
43.

Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.

Del Giudice G, Cheng Q, Mazier D, Berbiguier N, Cooper JA, Engers HD, Chizzolini C, Verdini AS, Bonelli F, Pessi A, et al.

Immunology. 1988 Feb;63(2):187-91.

44.

Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

Del Giudice G, Engers HD, Tougne C, Biro SS, Weiss N, Verdini AS, Pessi A, Degremont AA, Freyvogel TA, Lambert PH, et al.

Am J Trop Med Hyg. 1987 Mar;36(2):203-12.

PMID:
2435181
46.

Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.

Del Giudice G, Verdini AS, Pinori M, Pessi A, Verhave JP, Tougne C, Ivanoff B, Lambert PH, Engers HD.

J Clin Microbiol. 1987 Jan;25(1):91-6.

47.

Simplification and standardization of serodiagnostic tests for leprosy based on phenolic glycolipid-I (PG-I) antigen.

Aguado Sanchez G, Malik A, Tougne C, Lambert PH, Engers HD.

Lepr Rev. 1986 Dec;57 Suppl 2:83-93. No abstract available.

PMID:
3573946
48.

Cells of T-lymphocyte origin produce an erythropoietin-like growth factor.

Fagg B, Engers HD.

Exp Hematol. 1986 Dec;14(11):1006-10.

PMID:
3490989
49.

The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

Del Giudice G, Cooper JA, Merino J, Verdini AS, Pessi A, Togna AR, Engers HD, Corradin G, Lambert PH.

J Immunol. 1986 Nov 1;137(9):2952-5.

PMID:
3531341
50.

Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.

Togna AR, Del Giudice G, Verdini AS, Bonelli F, Pessi A, Engers HD, Corradin G.

J Immunol. 1986 Nov 1;137(9):2956-60.

PMID:
2428881

Supplemental Content

Loading ...
Support Center